{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T21:31:48Z","timestamp":1785706308951,"version":"3.56.0"},"reference-count":51,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006250","type":"journal-article","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T00:02:14Z","timestamp":1161302534000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Bisphosphonates for advanced prostate cancer"],"prefix":"10.1002","author":[{"given":"Kwok Keung","family":"Yuen","sequence":"first","affiliation":[{"name":"Tuen Mun Hospital; Department of Clinical Oncology; Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Shelley","sequence":"additional","affiliation":[{"name":"Velindre NHS Trust; Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept; Velindre Road Whitchurch Cardiff Wales UK CF4 7XL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Man","family":"Sze","sequence":"additional","affiliation":[{"name":"Pamela Youde Nethersole Eastern Hospital; Clinical Oncology; LG1 East Block 3 Lok Man Road Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Wilt","sequence":"additional","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Mason","sequence":"additional","affiliation":[{"name":"Velindre Hospital; Clinical Oncology; Whitchurch Cardiff UK CF4 7XL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"key":"10.1002\/14651858.CD006250-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-642-83668-8_6","article-title":"Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma","volume":"116","author":"Adami","year":"1989","journal-title":"Recent Results in Cancer Research 116: 67-72,"},{"issue":"No 17","key":"10.1002\/14651858.CD006250-BIB0002|cit2","first-page":"1300","article-title":"A double-blind, placebo-controlled, randomised trial of oral sodium clodronate for metastatic prostate cancer (MRC PRO5 Trial)","volume":"95","author":"Dearnaley","year":"2003","journal-title":"Journal of the National Cancer Institute, vol 95, No 17 Sep 3, 1300-11,"},{"key":"10.1002\/14651858.CD006250-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02549644","article-title":"Effect of oral clodronate on bone pain: A controlled study in patients with metastatic prostate cancer.","volume":"24 (2)","author":"Elomma","year":"1992","journal-title":"International Journal of Urology and Nephrology"},{"issue":"Sept 1 (17)","key":"10.1002\/14651858.CD006250-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1200\/JCO.2003.03.042","article-title":"Randomized, double-blind, controlled trial of mitoxantron\/prednisone and clodronate versus mitoxantrone\/prednisone and placebo in patiens with hormone-refractory prostate cancer and pain","volume":"21","author":"Ernst","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006250-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0959-8049(05)80417-4","article-title":"Evaluation of the effect of oral clodronate on skeletal metastases with type I collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group","volume":"29A","author":"Kylmala","year":"1993","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006250-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bjc.1997.488","article-title":"Concomitant i.v. and oral clodronate in the relief of bone pain: A double-blind placebo-controlled study in patients with metastatic prostate cancer","volume":"76","author":"Kylmala","year":"1997","journal-title":"British Journal of Cancer"},{"issue":"No 19","key":"10.1002\/14651858.CD006250-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"Journal of the National Cancer Institute 94: 1458-68,"},{"issue":"No 23 (Dec1)","key":"10.1002\/14651858.CD006250-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1200\/JCO.2003.05.147","article-title":"Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostatic cancer","volume":"21","author":"Small","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006250-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)40597-0","article-title":"Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study","volume":"141","author":"Smith","year":"1989","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD006250-BIB0010|cit10","first-page":"4717","article-title":"The analgesic efficacy of clodronate compared with placebo inpatients with painful bone metastases from prostatic cancer","volume":"17","author":"Strang","year":"1997","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD006250-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-5347(17)47663-4","article-title":"Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton","volume":"134","author":"Adami","year":"1985","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD006250-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0090-4295(88)90410-4","article-title":"Treatment of painful prostatic bone metastases with oral etidronate disodium","volume":"32","author":"Carey","year":"1988","journal-title":"Urology"},{"issue":"3","key":"10.1002\/14651858.CD006250-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bjc.1991.97","article-title":"Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study","volume":"63","author":"Clarke","year":"1991","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD006250-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1464-410X.1995.tb07715.x","article-title":"Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer","volume":"76","author":"Cresswell","year":"1995","journal-title":"British Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD006250-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000421-199710000-00007","article-title":"Skeletal response to clodronate in prostate cancer with bone metastases.","volume":"20","author":"Fernandez-Conde","year":"1997","journal-title":"American Journal of Clincial Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006250-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00005392-200101000-00033","article-title":"The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer","volume":"165","author":"Heidenreich","year":"2001","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD006250-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.pcan.4500574","article-title":"Ibandronate in the treatment of prostate cancer associated painful osseous metastases","volume":"5","author":"Heidenreich","year":"2002","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"10.1002\/14651858.CD006250-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1023\/A:1012506426440","article-title":"Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease","volume":"12","author":"Jagdev","year":"2001","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006250-BIB0019|cit19","first-page":"316","article-title":"The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer","volume":"83","author":"Kylmala","year":"1994","journal-title":"Annales Chirurgiae et Gynaecologiae"},{"issue":"8 Pt 1","key":"10.1002\/14651858.CD006250-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/clinchem\/44.8.1621","article-title":"Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by location of pain","volume":"44","author":"Magnusson","year":"1998","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD006250-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S8756-3282(97)00289-5","article-title":"Effects of the bisphosphonate olpadronate in patients with carcinoma of prostate metastatic to the skeleton","volume":"22","author":"Pelger","year":"1998","journal-title":"Bone"},{"key":"10.1002\/14651858.CD006250-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0959-8049(94)90287-9","article-title":"The effect of clodronate on bone in metastatic prostate cancer: Histomorphonmetric report of a double-blind randomised placebo-controlled study","volume":"30","author":"Taube","year":"1994","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006250-BIB0023|cit23","first-page":"63","article-title":"Clodronate in the palliative therapy of bone-metastasized prostate carcinoma","volume":"31(2)","author":"Vorreuther","year":"1992","journal-title":"Urologe A"},{"key":"10.1002\/14651858.CD006250-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1464-410X.1993.tb16269.x","article-title":"Bisphosphonates as an adjunct to palliative therapy of bone metastases from prostate carcinoma. A pilot study on clodronate.","volume":"72 (5 Pt 2)","author":"Vorreuther","year":"1993","journal-title":"British Journal of Urology"},{"issue":"S8","key":"10.1002\/14651858.CD006250-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.0.CO;2-X","article-title":"Bisphosphonates in prostate cancer","volume":"80","author":"Adami","year":"1997","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD006250-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomised controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"The Journal of the American Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD006250-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Human Pathology"},{"issue":"7441","key":"10.1002\/14651858.CD006250-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.328.7441.702","article-title":"CONSORT statement: extension to cluster randomised trials","volume":"328","author":"Campbell","year":"2004","journal-title":"British Medical Journal"},{"issue":"12 suppl","key":"10.1002\/14651858.CD006250-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q","article-title":"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma","volume":"88","author":"Carlin","year":"2000","journal-title":"Cancer"},{"issue":"3 suppl","key":"10.1002\/14651858.CD006250-BIB0030|cit30","first-page":"866","article-title":"Bone Cancer Pain","volume":"97","author":"Clohisy","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD006250-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD006250-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00002281-200007000-00017","article-title":"Treatment of bone diseases with bisphosphonates, excluding osteoporosis","volume":"12","author":"Devogelaer","year":"2000","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1002\/14651858.CD006250-BIB0033|cit33","first-page":"Art. No CD 0031","article-title":"Bisphosphonates in multiple myeloma","volume":"Issue 4","author":"Djulbegovic","year":"2002","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006250-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0305-7372(03)00071-9","article-title":"Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment","volume":"29","author":"Eaton","year":"2003","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD006250-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","article-title":"Development of bisphosphonates","volume":"4","author":"Fleisch","year":"2002","journal-title":"Breast Cancer Research"},{"key":"10.1002\/14651858.CD006250-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(96)07393-X","article-title":"Prostate cancer diagnosis and treatment","volume":"349","author":"Frydenberg","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006250-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1634\/theoncologist.7-4-360","article-title":"State-of-the-art treatment of metastatic hormone-refractory prostate cancer","volume":"7","author":"Goodin","year":"2002","journal-title":"The Oncologist"},{"issue":"7211","key":"10.1002\/14651858.CD006250-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD006250-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpedi.152.8.812","article-title":"Guides for reading and interpreting systematic reviews: II. How did the authors find the studies and assess their qualtiy?","volume":"152","author":"Jadad","year":"1998","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"7303","key":"10.1002\/14651858.CD006250-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD006250-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpedi.152.9.915","article-title":"Guides for reading and interpreting systematic reviews: III. How did the authors synthesize the data and make their conclusions?","volume":"152","author":"Moher","year":"1998","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1002\/14651858.CD006250-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Moher D Cook DJ Jadad AR Tugwell P Moher M Jones A Pham B KlassenTP Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses Health Technology Assessment 1999","DOI":"10.3310\/hta3120"},{"key":"10.1002\/14651858.CD006250-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1634\/theoncologist.8-2-161","article-title":"Cinical approaches to osseous metastases in prostate cancer","volume":"8","author":"Morris","year":"2003","journal-title":"The Oncologist"},{"issue":"3, Art No. CD00","key":"10.1002\/14651858.CD006250-BIB0044|cit44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003474.pub2","article-title":"Bisphosphonates for breast cancer","author":"Pavlakis","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006250-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00002281-200307000-00014","article-title":"Bisphosphonates: new indications and methods of administration","volume":"15","author":"Reid","year":"2003","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1002\/14651858.CD006250-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eururo.2003.10.003","article-title":"Role of bisphosphonates in prostate cancer","volume":"45","author":"Saad","year":"2004","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD006250-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","article-title":"The antineoplastic role of bisphosphonates: from basic reasearch to clinical evidence","volume":"14","author":"Santini","year":"2003","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006250-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1191\/0269216304pm914ra","article-title":"Systematic review of bisphosphonates for hypercalcaemia of malignancy","volume":"18","author":"Saunders","year":"2004","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006250-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"issue":"2, Art No. CD00","key":"10.1002\/14651858.CD006250-BIB0050|cit50","article-title":"Bisphosphonates for the relief of pain secondary to bone metastases","author":"Wong","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"S8","key":"10.1002\/14651858.CD006250-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.0.CO;2-X","article-title":"Bisphosphonates in prostate carcinoma","volume":"80","author":"Adami","year":"1997","journal-title":"Cancer"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006250.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T00:00:00Z","timestamp":1514246400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006250\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:56:57Z","timestamp":1628531817000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006250"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006250","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006250.pub2","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,18]]}}}